Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 2930

Showing 1-25 of 2930 citing articles:

Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch, et al.
Cell (2023) Vol. 186, Iss. 4, pp. 693-714
Open Access | Times Cited: 769
Alzheimer's disease drug development pipeline: 2022
Jeffrey L. Cummings, Garam Lee, Pouyan Nahed, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 526
Alzheimer's disease drug development pipeline: 2021
Jeffrey L. Cummings, Garam Lee, Kate Zhong, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 414
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Chao Gao, Jingwen Jiang, Yuyan Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 391
The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 388
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen, Inge M.W. Verberk, Elisabeth H. Thijssen, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 66-77
Open Access | Times Cited: 353
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Giovanni B. Frisoni, Daniele Altomare, Dietmar Rudolf Thal, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 1, pp. 53-66
Open Access | Times Cited: 326
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
Rik Ossenkoppele, Rik van der Kant, Oskar Hansson
The Lancet Neurology (2022) Vol. 21, Iss. 8, pp. 726-734
Open Access | Times Cited: 276
Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia
Ligia J. Domínguez, Nicola Veronese, Laura Vernuccio, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4080-4080
Open Access | Times Cited: 260
Impact of Mediterranean Diet on Chronic Non-Communicable Diseases and Longevity
Ligia J. Domínguez, Giovanna Di Bella, Nicola Veronese, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 2028-2028
Open Access | Times Cited: 227
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
Rik Ossenkoppele, Ruben Smith, Niklas Mattsson, et al.
JAMA Neurology (2021) Vol. 78, Iss. 8, pp. 961-961
Open Access | Times Cited: 218
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Juan Fortea, Shahid Zaman, Sigan L. Hartley, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 11, pp. 930-942
Open Access | Times Cited: 204
Biomarkers of aging
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 192
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Emily Sun, Aishat Motolani, Leonardo Campos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8972-8972
Open Access | Times Cited: 185
Forsythoside A Mitigates Alzheimer's-like Pathology by Inhibiting Ferroptosis-mediated Neuroinflammation via Nrf2/GPX4 Axis Activation
Chunyue Wang, Shanshan Chen, Hangyu Guo, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 5, pp. 2075-2090
Open Access | Times Cited: 182
Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
Eric McDade, Jeffrey L. Cummings, Shobha Dhadda, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 168
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 166
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Ana Guerrero, Bart De Strooper, I. Lorena Arancibia-Cárcamo
Trends in Neurosciences (2021) Vol. 44, Iss. 9, pp. 714-727
Open Access | Times Cited: 164
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Willemijn J. Jansen, Olin Janssen, Betty M. Tijms, et al.
JAMA Neurology (2022) Vol. 79, Iss. 3, pp. 228-228
Open Access | Times Cited: 161
Applications of multi‐omics analysis in human diseases
Chongyang Chen, Jing Wang, Donghui Pan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 159
Mental health care for older adults: recent advances and new directions in clinical practice and research
Charles F. Reynolds, Dilip V. Jeste, Perminder S. Sachdev, et al.
World Psychiatry (2022) Vol. 21, Iss. 3, pp. 336-363
Open Access | Times Cited: 155
Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial
Giacomo Koch, Elias Paolo Casula, Sonia Bonnı̀, et al.
Brain (2022) Vol. 145, Iss. 11, pp. 3776-3786
Open Access | Times Cited: 141
Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Elena Tamagno, Michela Guglielmotto, Valeria Vasciaveo, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1479-1479
Open Access | Times Cited: 140
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 139
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Moxin Wu, Manqing Zhang, Xiaoping Yin, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 123
Page 1 - Next Page

Scroll to top